AU631223B2 - Improved baculovirus expression vectors - Google Patents

Improved baculovirus expression vectors Download PDF

Info

Publication number
AU631223B2
AU631223B2 AU58207/90A AU5820790A AU631223B2 AU 631223 B2 AU631223 B2 AU 631223B2 AU 58207/90 A AU58207/90 A AU 58207/90A AU 5820790 A AU5820790 A AU 5820790A AU 631223 B2 AU631223 B2 AU 631223B2
Authority
AU
Australia
Prior art keywords
promoter
baculovirus
gene
modified
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU58207/90A
Other languages
English (en)
Other versions
AU5820790A (en
Inventor
Lois K. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc UGARF
Original Assignee
University of Georgia Research Foundation Inc UGARF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc UGARF filed Critical University of Georgia Research Foundation Inc UGARF
Publication of AU5820790A publication Critical patent/AU5820790A/en
Application granted granted Critical
Publication of AU631223B2 publication Critical patent/AU631223B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU58207/90A 1989-05-17 1990-05-17 Improved baculovirus expression vectors Ceased AU631223B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35384789A 1989-05-17 1989-05-17
US353847 1989-05-17

Publications (2)

Publication Number Publication Date
AU5820790A AU5820790A (en) 1990-12-18
AU631223B2 true AU631223B2 (en) 1992-11-19

Family

ID=23390826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58207/90A Ceased AU631223B2 (en) 1989-05-17 1990-05-17 Improved baculovirus expression vectors

Country Status (5)

Country Link
EP (1) EP0426840A1 (fr)
JP (1) JPH04501065A (fr)
AU (1) AU631223B2 (fr)
CA (1) CA2033070A1 (fr)
WO (1) WO1990014428A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022442A1 (fr) * 1992-04-29 1993-11-11 Boyce Thompson Institute For Plant Research, Inc. Infection orale de larves d'insecte par des particules pre-occluses de baculovirus
US6090379A (en) * 1992-04-29 2000-07-18 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle for use in recombinant protein production and pesticides
US5593669A (en) * 1992-04-29 1997-01-14 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle
FR2715664B1 (fr) * 1994-01-31 1996-04-12 Proteine Performance Sa Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
US6846481B1 (en) 1999-02-04 2005-01-25 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US7326568B2 (en) 1999-02-04 2008-02-05 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US7026156B1 (en) 1999-02-04 2006-04-11 The University Of Georgia Research Foundation, Inc. Diagnostic and protective antigen gene sequences of ichthyophthirius
JP4896745B2 (ja) 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
AU2005265163B2 (en) 2004-06-18 2009-10-01 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
CN101087875B (zh) 2004-12-22 2012-08-22 Ambrx公司 氨酰基-tRNA合成酶的组合物及其用途
CA2927595C (fr) 2004-12-22 2023-01-31 Ambrx, Inc. Compositions contenant des acides amines non naturels et des polypeptides, procedes impliquant ces acides amines non naturels et polypeptides, et utilisations desdits acides amines non naturels et polypeptides
US7816320B2 (en) 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
CN103690936A (zh) 2004-12-22 2014-04-02 Ambrx公司 经修饰的人类生长激素
US8080391B2 (en) 2004-12-22 2011-12-20 Ambrx, Inc. Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer
SG165353A1 (en) 2005-06-03 2010-10-28 Ambrx Inc Improved human interferon molecules and their uses
PT2339014E (pt) 2005-11-16 2015-10-13 Ambrx Inc Métodos e composições compreendendo aminoácidos não-naturais
JP5840345B2 (ja) 2006-09-08 2016-01-06 アンブルックス, インコーポレイテッドAmbrx, Inc. 修飾ヒト血漿ポリペプチドまたは修飾ヒトＦｃ足場タンパク質ならびにこれらの利用
US9133495B2 (en) 2006-09-08 2015-09-15 Ambrx, Inc. Hybrid suppressor tRNA for vertebrate cells
ES2465473T3 (es) 2006-09-08 2014-06-05 Ambrx, Inc. Transcripción de arnt supresor en células de vertebrado
ATE554785T1 (de) 2007-03-30 2012-05-15 Ambrx Inc Modifizierte fgf-21 polypeptide und ihre verwendung
JP2010525821A (ja) 2007-05-02 2010-07-29 アンブルックス，インコーポレイテッド 修飾ＩＦＮβポリペプチドおよびこれらの使用
DK2217265T3 (en) 2007-11-20 2017-07-03 Ambrx Inc Modified insulin polypeptides and their use
EP2247743B1 (fr) 2008-02-08 2016-04-06 Ambrx, Inc. Polypeptides leptine modifiés et leurs utilisations
BRPI0916515B8 (pt) 2008-07-23 2021-07-27 Ambrx Inc polipeptídeo de fator estimulante de colônias de granulócitos bovino (bg-csf), formulação farmacêutica e composição compreendendo o mesmo
MX346001B (es) 2008-09-26 2017-03-01 Ambrx Inc Polipeptidos de eritropoyetina animal modificados y sus usos.
BRPI0919031A2 (pt) 2008-09-26 2014-09-23 Ambrx Inc Micro-organismos e vacinas dependentes de replicação através do uso de aminoácidos não naturais
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
AU2010341518B2 (en) 2009-12-21 2014-01-09 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
EP4302783A3 (fr) 2010-08-17 2024-03-13 Ambrx, Inc. Polypeptides de relaxine modifiés et leurs utilisations
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
PT3412302T (pt) 2014-10-24 2021-06-09 Bristol Myers Squibb Co Polipéptidos de fgf-21 modificados e utilizações dos mesmos
TW201837051A (zh) 2017-02-08 2018-10-16 美商必治妥美雅史谷比公司 包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3529189A (en) * 1988-05-31 1989-12-07 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes
AU5187190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Improved baculovirus expression system capable of producing foreign gene proteins at high levels

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3529189A (en) * 1988-05-31 1989-12-07 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes
AU5187190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Improved baculovirus expression system capable of producing foreign gene proteins at high levels

Also Published As

Publication number Publication date
WO1990014428A1 (fr) 1990-11-29
CA2033070A1 (fr) 1990-11-18
AU5820790A (en) 1990-12-18
JPH04501065A (ja) 1992-02-27
EP0426840A1 (fr) 1991-05-15

Similar Documents

Publication Publication Date Title
AU631223B2 (en) Improved baculovirus expression vectors
US5244805A (en) Baculovirus expression vectors
EP0549721B1 (fr) Systeme d'expression de baculovirus a promoteurs multiples et production de particules defectives
Tessier et al. Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide
US5194376A (en) Baculovirus expression system capable of producing foreign gene proteins at high levels
US5516657A (en) Baculovirus vectors for expression of secretory and membrane-bound proteins
US4745051A (en) Method for producing a recombinant baculovirus expression vector
JP3183877B2 (ja) 修飾バキュロウイルス、その調整方法及びそれの形質発現ベクターとしての適用
US4879236A (en) Method for producing a recombinant baculovirus expression vector
US5518913A (en) High level recombinant protein production using conditional helper-free adenovirus vector
US5278050A (en) Method to improve the efficiency of processing and secretion of foreign genes in insect systems
US6090584A (en) Baculovirus artificial chromosomes and methods of use
NO173944B (no) Fremgangsmaate for fremstilling av en rekombinant baculovirus-ekspresjonsvektor
US5322774A (en) Procaryotic leader sequence in recombinant baculovirus expression system
EP0397485A1 (fr) Vecteurs d'expression de baculovirus et leur utilisation pour l'expression de protéines étrangères dans des insectes ou cellules d'insectes
EP0228036A2 (fr) Méthode de production de polypeptides sélectionnés dans des cellules d'insectes infectées par des virus et polypeptides ainsi isolés
JPH0365191A (ja) スフェロイジン単離ｄｎａおよび組み換え昆虫ポックスウィルス発現ベクター
Beljelarskaya A baculovirus expression system for insect cells
AU684799B2 (en) Gene insertion by direct ligation (in vitro)
US6037150A (en) Insect sequences for improving the efficiency of secretion of non-secreted proteins in eukaryotic cells
WO1998050571A1 (fr) Vecteur d'administration de gene a base d'entomopoxvirus pour vertebres
CA1330425C (fr) Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantite
GB2228486A (en) Improved baculovirus expression system capable of producing foreign gene proteins at high levels
Heldens et al. Generation of a p10-based baculovirus expression vector in yeast with infectivity for insect larvae and insect cells
Hong et al. Comparison Promoter Activity of the p10 Gene between Bombyx mori Nucleopolyhedrovirus Variants